Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,683 public trials 1,032 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Active, Not Recruiting

Osimertinib In EGFR Mutant Lung Cancer

NCT03586453

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Testing the Safety of M6620 (VX-970) When Given With Standard Whole Brain Radiation Therapy for the Treatment of Brain Metastases From Non-small Cell Lung Cancer, Small Cell Lung Cancer, or Neuroendocrine Tumors

NCT02589522

Conditions
Brain Diseases, Brain Neoplasms, Bronchial Neoplasms, +21 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • University of Kentucky/Markey Cancer Center Lexington, Kentucky, United States
View Trial Details
Active, Not Recruiting

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

NCT04913285

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +25 more
Locations
  • The Angeles Clinic Los Angeles, California, United States
  • UCLA Los Angeles, California, United States
  • University of California San Diego, Moores Cancer Center San Diego, California, United States
  • University of California San Francisco San Francisco, California, United States
View all 50 locations
View Trial Details
Active, Not Recruiting

POTENT - Tepotinib in Combination With Pembrolizumab in NSCLC

NCT05782361

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • DDU, Royal Marsden Hospital NHS Foundation Trust Sutton, Surrey, United Kingdom
  • University College London Hospitals NHS Foundation Trust London, United Kingdom
  • Lung Unit, Royal Marsden Hospital NHS Foundation Trust London, United Kingdom
  • The Christie NHS Foundation Trust Manchester, United Kingdom
View Trial Details
Active, Not Recruiting

A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation

NCT04280081

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +25 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • The First Affiated Hospital Of Guangzhou Medical University Guangzhou, Guangdong, China
  • Southern Medical University Nanfang Hospital Guangzhou, Guangdong, China
  • Hunan Cancer Hospital Changsha, Hunan, China
View all 13 locations
View Trial Details
Active, Not Recruiting

Whole Genomic Landscape of Advanced EGFR-mutant NSCLC

NCT03969823

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Seoul National University Bundang Hospital Seongnam, South Korea
  • Borame Medical Center Seoul, South Korea
  • Seoul National University Hospital Seoul, South Korea
View Trial Details

Related conditions